Rolinsatamab is a fully humanized selective monoclonal antibody that is a potent dual inhibitor of IL-4 and IL-13. Rolinsatamab chimeric antigen receptor sequence T cells. Rolinsatamab can be used to prevent and treat immune diseases.
CAS Number:
[2095467-30-2]
Target:
IL Receptor
* VAT and and shipping costs not included. Errors and price changes excepted